The Safety and Efficacy of Allogeneic CD70 CAR-T Therapy in Unresectable or Metastatic Clear Cell Renal Cell Carcinoma

NCT07645690 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Unresectable or Metastatic Clear Cell Renal Cell Carcinoma

Interventions

BIOLOGICAL: CLEAR CAR-T cell injection

Sponsor

Chinese PLA General Hospital